Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels

Neurotransmitters such as serotonin (5-hydroxytryptamine, 5-HT) work closely with leptin and insulin to fine-tune the metabolic and neuroendocrine responses to dietary intake. Losing the sensitivity to excess food intake can lead to obesity, diabetes, and a multitude of behavioral disorders. It is l...

Full description

Bibliographic Details
Main Authors: Zhang, Y., Smith, E., Baye, T., Eckert, J., Abraham, L., Moses, Eric, Kissebah, A., Martin, L., Olivier, M.
Format: Journal Article
Published: 2010
Online Access:http://hdl.handle.net/20.500.11937/4444
_version_ 1848744517176393728
author Zhang, Y.
Smith, E.
Baye, T.
Eckert, J.
Abraham, L.
Moses, Eric
Kissebah, A.
Martin, L.
Olivier, M.
author_facet Zhang, Y.
Smith, E.
Baye, T.
Eckert, J.
Abraham, L.
Moses, Eric
Kissebah, A.
Martin, L.
Olivier, M.
author_sort Zhang, Y.
building Curtin Institutional Repository
collection Online Access
description Neurotransmitters such as serotonin (5-hydroxytryptamine, 5-HT) work closely with leptin and insulin to fine-tune the metabolic and neuroendocrine responses to dietary intake. Losing the sensitivity to excess food intake can lead to obesity, diabetes, and a multitude of behavioral disorders. It is largely unclear how different serotonin receptor subtypes respond to and integrate metabolic signals and which genetic variations in these receptor genes lead to individual differences in susceptibility to metabolic disorders. In an obese cohort of families of Northern European descent (n = 2,209), the serotonin type 5A receptor gene, HTR5A, was identified as a prominent factor affecting plasma levels of triglycerides (TG), supported by our data from both genome-wide linkage and targeted association analyses using 28 publicly available and 12 newly discovered single nucleotide polymorphisms (SNPs), of which 3 were strongly associated with plasma TG levels (P < 0.00125). Bayesian quantitative trait nucleotide (BQTN) analysis identified a putative causal promoter SNP (rs3734967) with substantial posterior probability (P = 0.59). Functional analysis of rs3734967 by electrophoretic mobility shift assay (EMSA) showed distinct binding patterns of the two alleles of this SNP with nuclear proteins from glioma cell lines. In conclusion, sequence variants in HTR5A are strongly associated with high plasma levels of TG in a Northern European population, suggesting a novel role of the serotonin receptor system in humans. This suggests a potential brain-specific regulation of plasma TG levels, possibly by alteration of the expression of HTR5A. Copyright © 2010 the American Physiological Society.
first_indexed 2025-11-14T06:02:43Z
format Journal Article
id curtin-20.500.11937-4444
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:02:43Z
publishDate 2010
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-44442023-02-22T06:24:22Z Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels Zhang, Y. Smith, E. Baye, T. Eckert, J. Abraham, L. Moses, Eric Kissebah, A. Martin, L. Olivier, M. Neurotransmitters such as serotonin (5-hydroxytryptamine, 5-HT) work closely with leptin and insulin to fine-tune the metabolic and neuroendocrine responses to dietary intake. Losing the sensitivity to excess food intake can lead to obesity, diabetes, and a multitude of behavioral disorders. It is largely unclear how different serotonin receptor subtypes respond to and integrate metabolic signals and which genetic variations in these receptor genes lead to individual differences in susceptibility to metabolic disorders. In an obese cohort of families of Northern European descent (n = 2,209), the serotonin type 5A receptor gene, HTR5A, was identified as a prominent factor affecting plasma levels of triglycerides (TG), supported by our data from both genome-wide linkage and targeted association analyses using 28 publicly available and 12 newly discovered single nucleotide polymorphisms (SNPs), of which 3 were strongly associated with plasma TG levels (P < 0.00125). Bayesian quantitative trait nucleotide (BQTN) analysis identified a putative causal promoter SNP (rs3734967) with substantial posterior probability (P = 0.59). Functional analysis of rs3734967 by electrophoretic mobility shift assay (EMSA) showed distinct binding patterns of the two alleles of this SNP with nuclear proteins from glioma cell lines. In conclusion, sequence variants in HTR5A are strongly associated with high plasma levels of TG in a Northern European population, suggesting a novel role of the serotonin receptor system in humans. This suggests a potential brain-specific regulation of plasma TG levels, possibly by alteration of the expression of HTR5A. Copyright © 2010 the American Physiological Society. 2010 Journal Article http://hdl.handle.net/20.500.11937/4444 10.1152/physiolgenomics.00038.2010 unknown
spellingShingle Zhang, Y.
Smith, E.
Baye, T.
Eckert, J.
Abraham, L.
Moses, Eric
Kissebah, A.
Martin, L.
Olivier, M.
Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
title Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
title_full Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
title_fullStr Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
title_full_unstemmed Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
title_short Serotonin (5-HT) receptor 5A sequence variants affect human plasma triglyceride levels
title_sort serotonin (5-ht) receptor 5a sequence variants affect human plasma triglyceride levels
url http://hdl.handle.net/20.500.11937/4444